Adapted physical activity program for children and teenagers with Osteogenesis Imperfecta
BONeMOVE : an Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Osteogenesis Imperfecta: an Interventional, Prospective, Regional, Bicentric Study.
This study tests if a special 6-month exercise program can help children and teenagers with Osteogenesis Imperfecta improve their energy levels and overall fitness.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 7 Years to 18 Years |
| Sex | All |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 2 sites (Montpellier and 1 other locations) |
| Trial ID | NCT05927389 on ClinicalTrials.gov |
What this trial studies
This research evaluates the impact of a 6-month adapted physical activity program on the endurance capacities of children and adolescents diagnosed with Osteogenesis Imperfecta. The study focuses on improving maximum oxygen consumption (VO2 peak) to address chronic fatigue and decreased physical endurance commonly experienced by these patients. By engaging in tailored physical activities, the program aims to enhance muscle function and overall quality of life for participants. The study is conducted at University Hospital in Toulouse and CHU Montpellier.
Who should consider this trial
Good fit: Ideal candidates for this study are children and adolescents diagnosed with Osteogenesis Imperfecta who can walk and have parental consent.
Not a fit: Patients who are non-walking, pregnant, breastfeeding, or participating in other interventional research may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the physical endurance and quality of life for children and teenagers with Osteogenesis Imperfecta.
How similar studies have performed: Previous studies have shown that physical activity can improve muscle function and quality of life in patients with chronic diseases, suggesting potential success for this approach in Osteogenesis Imperfecta.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed Osteogenesis Imperfecta * Informed and written consent signed by at least one of the two holders of parental authority * Patient affiliated to a social security scheme or equivalent Exclusion Criteria: * Non-walking children (unable to perform the effort test) * Pregnant or breastfeeding * Participation in other interventional research
Where this trial is running
Montpellier and 1 other locations
- CHU Montpellier Hôpital Arnaud de Villeneuve — Montpellier, France (Not_yet_recruiting)
- CHU Toulouse — Toulouse, France (Recruiting)
Study contacts
- Principal investigator: Thomas EDOUARD, MD — University Hospital, Toulouse
- Study coordinator: Thomas EDOUARD, MD
- Email: edouard.t@chu-toulouse.fr
- Phone: 05 61 77 61 10
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.